Cost effectiveness of mosunetuzumab and CAR-T cell therapy in relapsed/refractory follicular lymphoma., PMID:40488632
Potent candidates for Targeted Alpha Therapy (TAT)., PMID:40424694
Health and Economic Impact of Vein-to-Vein Time in CAR T-Cell Therapy in the Second-Line Treatment of Relapsed/Refractory Large B-Cell Lymphoma: A US Cost-Effectiveness Analysis., PMID:40373976
Affinity maturation and optimization of CD44v6-targeting antibodies for molecular radiotherapy., PMID:40253776
Investigating the fate of Zirconium-89 labelled antibody in cynomolgus macaques., PMID:39985867
A Markov model assessing the cost-effectiveness of various anti-vascular endothelial growth factor drugs and panretinal photocoagulation for the treatment of proliferative diabetic retinopathy., PMID:39910280
Cost-effectiveness analysis of PD-L1 testing associated with pembrolizumab for first-line treatment of advanced non-small cell lung cancer in China., PMID:39804416
Pretargeted alpha therapy in MUC16-positive high-grade serous ovarian cancer., PMID:39615062
225Aс/213Bi generator for direct synthesis of 213Bi-labeled bioconjugates., PMID:39603113
New prospects for 89Zr-immuno-PET in brain applications - Alpha-synucleinopathies., PMID:39591759
Convection-enhanced delivery of [177Lu]Lu-labeled gold nanoparticles combined with anti-PD1 checkpoint immunotherapy improves the survival of immunocompetent C57BL/6J mice with orthotopic GL261 murine glioma tumors., PMID:39571483
Using Genomic Heterogeneity to Inform Therapeutic Decisions for Metastatic Colorectal Cancer: An Application of the Value of Heterogeneity Framework., PMID:39520611
Secretion of GPNMB from Neural Stem Cells Induced by ET-1 Contributes to Angiogenesis after Spinal Cord Injury., PMID:39327246
Functional status and quality of life in older patients with advanced esophageal squamous cell cancer receiving second-line nivolumab ± ipilimumab therapy: A post hoc analysis of the phase 2, multicenter RAMONA study., PMID:39097500
Phase 1 study of the pharmacokinetics and clinical proof-of-concept activity of a biofilm-disrupting human monoclonal antibody in patients with chronic prosthetic joint infection of the knee or hip., PMID:39012102
Transcatheter pseudo-vascular isolation for localization and concentration of a large molecule theranostic probe into a transgenic OncoPIG kidney tumor., PMID:39003976
Combining poly-epitope MoonTags and labeled nanobodies for signal amplification in cell-specific PET imaging in vivo., PMID:38964257
Target engagement of an anti-MT1-MMP antibody for triple-negative breast cancer PET imaging and beta therapy., PMID:38833768
Prediction by genetic MATS of 4CMenB vaccine strain coverage of invasive meningococcal serogroup B isolates circulating in Taiwan between 2003 and 2020., PMID:38752729
Expression of Potential Antibody-Drug Conjugate Targets in Cervical Cancer., PMID:38730739
Initial insights into the interaction of antibodies radiolabeled with Lutetium-177 and Actinium-225 with tumor microenvironment in experimental human and canine osteosarcoma., PMID:38718557
Cost-effectiveness analysis of mosunetuzumab for treatment of relapsed or refractory follicular lymphoma after two or more lines of systemic therapy in the United States., PMID:38712895
PSMA-reactive NB7 single domain antibody fragment: A potential scaffold for developing prostate cancer theranostics., PMID:38703588
Reduction of the hepatic radioactivity levels of [111In]In-DOTA-labeled antibodies via cleavage of a linkage metabolized in lysosomes., PMID:38636351
Synthesis and evaluation of novel trifunctional chelating agents for pretargeting approach using albumin binder to improve tumor accumulation., PMID:38614036
Monoclonal Antibody Disrupts Biofilm Structure and Restores Antibiotic Susceptibility in an Orthopedic Implant Infection Model., PMID:37887191
Use of expanded Neisseria meningitidis serogroup B panels with the serum bactericidal antibody assay for the evaluation of meningococcal B vaccine effectiveness., PMID:37622470
Relative Biological Effectiveness (RBE) of [64Cu]Cu and [177Lu]Lu-NOTA-panitumumab F (ab')2 radioimmunotherapeutic agents vs. γ-radiation for decreasing the clonogenic survival in vitro of human pancreatic ductal adenocarcinoma (PDAC) cells., PMID:37506639
Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2., PMID:37473513
SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma (2022)., PMID:37289353
Automated radiosynthesis of [89Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo., PMID:37224789
Nano magnetic-based ELISA and nano magnetic-based latex agglutination test for diagnosis of experimental trichinellosis., PMID:37193503
Visual acuity time in range: a novel concept to describe consistency in treatment response in diabetic macular oedema., PMID:36977936
Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosis., PMID:36963796
Cost-effectiveness analysis of myopia management: A systematic review., PMID:36923029
Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan., PMID:36884164
A radioiodinated rucaparib analogue as an Auger electron emitter for cancer therapy., PMID:36621256
Biologicals as theranostic vehicles in paediatric oncology., PMID:36126433
Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial., PMID:36098320
Critical Players and Therapeutic Targets in Chronic Itch., PMID:36077340
Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria., PMID:35921449
An alternative radiochemical separation strategy for isolation of Ac and Ra isotopes from high energy proton irradiated thorium targets for further application in Targeted Alpha Therapy (TAT)., PMID:35797877
Bismuth chelation for targeted alpha therapy: Current state of the art., PMID:35753940
Evaluation and selection of a lead diabody for interferon-γ PET imaging., PMID:35753939
Evaluation of 134Ce as a PET imaging surrogate for antibody drug conjugates incorporating 225Ac., PMID:35512517
Visualization of a novel human monoclonal antibody against Claudin-3 for targeting ovarian cancer., PMID:35501237
Passive and receptor mediated brain delivery of an anti-GFAP nanobody., PMID:35487832
Reduction of tumor hypoxia by anti-PD-1 therapy assessed using pimonidazole and [18F]FMISO., PMID:35367730
Mini-review: Antibody-PET of receptor tyrosine kinase interplay and heterogeneity., PMID:35339065
Radiation dosimetry and efficacy of an 89Zr/225Ac-labeled humanized anti-MUC5AC antibody., PMID:35276446
For research use only. Not for human or drug use.
